Cell replacement therapy holds great promise for Parkinson's disease (PD), but residual undifferentiated cells and immature neural progenitors in the therapy may cause tumor formation. Although cell sorting could effectively exclude these proliferative cells, from the viewpoint of clinical application, there exists no adequate coping strategy in the case of their contamination. In this study, we analyzed a component of proliferative cells in the grafts of human-induced pluripotent stem cell-derived neural progenitors and investigated the effect of radiation therapy on tumor formation. In our differentiating protocol, analyses of neural progenitors (day 19) revealed that the proliferating cells expressed early neural markers (SOX1, PAX6) or a dopaminergic neuron progenitor marker (FOXA2). When grafted into the rat striatum, these immature neurons gradually became postmitotic in the brain, and the rosette structures disappeared at 14 weeks. However, at 4–8 weeks, the SOX1+PAX6+ cells formed rosette structures in the grafts, suggesting their tumorigenic potential. Therefore, to develop a fail-safe therapy against tumor formation, we investigated the effect of radiation therapy. At 4 weeks posttransplantation, when KI67+ cells comprised the highest ratio, radiation therapy with 137Cs Gammacell Exactor for tumor-bearing immunodeficient rats showed a significant decrease in graft volume and percentage of SOX1+KI67+ cells in the graft, thus demonstrating the preventive effect of gamma-ray irradiation against tumorigenicity. These results give us critical criteria for the safety of future cell replacement therapy for PD.
Get full access to this article
View all access options for this article.
References
1.
PruszakJ, SonntagKC, AungMH, Sanchez-PernauteR and IsacsonO. (2007). Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populations. Stem Cells, 25:2257–2268.
2.
BrederlauA, CorreiaAS, AnisimovSV, ElmiM, PaulG, RoybonL, MorizaneA, BergquistF, RiebeI, et al. (2006). Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells, 24:1433–1440.
3.
WernigM, ZhaoJP, PruszakJ, HedlundE, FuD, SoldnerF, BroccoliV, Constantine-PatonM, IsacsonO and JaenischR. (2008). Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A, 105:5856–5861.
4.
RheeYH, KoJY, ChangMY, YiSH, KimD, KimCH, ShimJW, JoAY, KimBW, et al. (2011). Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. J Clin Invest, 121:2326–2335.
5.
MorizaneA, TakahashiJ, ShinoyamaM, IdeguchiM, TakagiY, FukudaH, KoyanagiM, SasaisY and HashimotoN. (2006). Generation of graftable dopaminergic neuron progenitors from mouse ES cells by a combination of coculture and neurosphere methods. J Neurosci Res, 83:1015–1027.
6.
DoiD, MorizaneA, KikuchiT, OnoeH, HayashiT, KawasakiT, MotonoM, SasaiY, SaikiH, et al. (2012). Prolonged maturation culture favors a reduction in the tumorigenicity and the dopaminergic function of human ESC-derived neural cells in a primate model of Parkinson's disease. Stem Cells, 30:935–945.
7.
ElkabetzY, PanagiotakosG, Al ShamyG, SocciND, TabarV and StuderL. (2008). Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Genes Dev, 15:152–165.
8.
CaiJ, YangM, PoremskyE, KiddS, SchneiderJS and IacovittiL. (2010). Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats. Stem Cells Dev, 19:1017–1023.
9.
KikuchiT, MorizaneA, DoiD, OnoeH, HayashiT, KawasakiT, SaikiH, MiyamotoS and TakahashiJ. (2011). Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson's disease. J Parkinsons Dis, 1:395–412.
10.
BorgheseL, DolezalovaD, OpitzT, HauptS, LeinhaasA, SteinfarzB, KochP, EdenhoferF, HamplA and BrüstleO. (2010). Inhibition of notch signaling in human embryonic stem cell-derived neural stem cells delays G1/S phase transition and accelerates neuronal differentiation in vitro and in vivo. Stem Cells, 28:955–964.
11.
OguraA, MorizaneA, NakajimaY, MiyamotoS and TakahashiJ. (2013). γ-secretase inhibitors prevent overgrowth of transplanted neural progenitors derived from human-induced pluripotent stem cells. Stem Cells Dev, 1:374–382.
12.
HargusG, CooperO, DeleidiM, LevyA, LeeK, MarlowE, YowA, SoldnerF, HockemeyerD, et al. (2010). Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci U S A, 107:15921–15926.
13.
PruszakJ, LudwigW, BlakA, AlavianK and IsacsonO. (2009). CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells. Stem Cells, 27:2928–2940.
14.
SundbergM, BogetofteH, LawsonT, JanssonJ, SmithG, AstradssonA, MooreM, OsbornT, CooperO, et al. (2013). Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons. Stem Cells, 8:1548–1562.
15.
DoiD, SamataB, KatsukawaM, KikuchiT, MorizaneA, OnoY, SekiguchiK, NakagawaM, ParmarM and TakahashiJ. (2014). Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation. Stem Cell Rep, 2:337–350.
16.
AcharyaMM, LanML, KanVH, PatelNH, GiedzinskiE, TsengBP and LimoliCL. (2010). Consequences of ionizing radiation-induced damage in human neural stem cells. Free Radic Biol Med, 15:1846–1855.
17.
LanML, AcharyaMM, TranKK, Bahari-KashaniJ, PatelNH, StrnadelJ, GiedzinskiE and LimoliCL. (2012). Characterizing the radioresponse of pluripotent and multipotent human stem cells. PLoS One, 7:e50048.
18.
SokolovM and NeumannR. (2013). Lessons learned about human stem cell responses to ionizing radiation exposures: a long road still ahead of us. Int J Mol Sci, 14:15695–15723.
19.
ThorsenF, EngerPØ, WangJ, BjerkvigR and PedersenPH. (2007). Human glioblastoma biopsy spheroids xenografted into the nude rat brain show growth inhibition after stereotactic radiosurgery. J Neurooncol, 82:1–10.
20.
MatsumuraK, IshiharaM, IchikiY, KobayashiY, SasakiK and KikuchiM. (2011). Development of Methods to Inhibit Tumorigenesis after Transplantation of Differentiated iPS Cells. Cytometry Res, 21:35–41.
21.
TakahashiK, TanabeK, OhnukiM, NaritaM, IchisakaT, TomodaK and YamanakaS. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131:861–872.
22.
OkitaK, YamakawaT, MatsumuraY, SatoY, AmanoN, WatanabeA, GoshimaN and YamanakaS. (2013). An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells, 31:458–466.
23.
SamataB, KikuchiT, MiyawakiY, MorizaneA, MashimoT, NakagawaM, OkitaK and TakahashiJ. (2015). X-linked severe combined immunodeficiency (X-SCID) rats for xeno-transplantation and behavioral evaluation. J Neurosci Methods, 243:68–77.
24.
ChambersSM, FasanoCA, PapapetrouEP, TomishimaM, SadelainM and StuderL. (2009). Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol, 27:275–280.
25.
KriksS, ShimJW, PiaoJ, GanatYM, WakemanDR, XieZ, Carrillo-ReidL, AuyeungG, AntonacciC, et al. (2011). Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature, 480:547–551.
26.
FrilingS, AnderssonE, ThompsonLH, JönssonME, HebsgaardJB, NanouE, AlekseenkoZ, MarklundU, KjellanderS, et al. (2009). Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells. Proc Natl Acad Sci U S A, 106:7613–7618.
27.
KittappaR, ChangWW, AwatramaniRB and McKayRD. (2007). The foxa2 gene controls the birth and spontaneous degeneration of dopamine neurons in old age. PLoS Biol, 5:12:e325.
28.
OnoY, NakataniT, SakamotoY, MizuharaE, MinakiY, KumaiM, HamaguchiA, NishimuraM, InoueY, et al. (2007). Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells. Development, 134:3213–3225.
29.
ChungS, MoonJI, LeungA, AldrichD, LukianovS, KitayamaY, ParkS, LiY, BolshakovVY, LamonerieT and KimKS. (2011). ES cell-derived renewable and functional midbrain dopaminergic progenitors. Proc Natl Acad Sci U S A, 108:9703–9708.
30.
SmidtMP and BurbachJP. (2007). How to make a mesodiencephalic dopaminergic neuron. Nat Rev Neurosci, 8:21–32.
31.
TabarV, PanagiotakosG, GreenbergED, ChanBK, SadelainM, GutinPH and StuderL. (2005). Migration and differentiation of neural precursors derived from human embryonic stem cells in the rat brain. Nat Biotechnol, 23:601–606.
32.
LiXJ, DuZW, ZarnowskaED, PankratzM, HansenLO, PearceRA and ZhangSC. (2005). Specification of motoneurons from human embryonic stem cells. Nat Biotechnol, 23:215–221.
33.
SonntagKC, PruszakJ, YoshizakiT, van ArensbergenJ, Sanchez-PernauteR and IsacsonO. (2007). Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem Cells, 25:411–418.
34.
UchikawaM, YoshidaM, Iwafuchi-DoiM, MatsudaK, IshidaY, TakemotoT and KondohH. (2011). B1 and B2 Sox gene expression during neural plate development in chicken and mouse embryos: universal versus species-dependent features. Dev Growth Differ, 53:761–771.
35.
HoffmanJA, WuCI and MerrillBJ. (2013). Tcf7l1 prepares epiblast cells in the gastrulating mouse embryo for lineage specification. Development, 140:1665–1675.
36.
SuterDM, TirefortD, JulienS and KrauseKH. (2009). A Sox1 to Pax6 switch drives neuroectoderm to radial glia progression during differentiation of mouse embryonic stem cells. Stem Cells, 27:49–58.
37.
KimJ and LauderdaleJD. (2006). Analysis of Pax6 expression using a BAC transgene reveals the presence of a paired-less isoform of Pax6 in the eye and olfactory bulb. Dev Biol, 292:486–505.
38.
KondziolkaD, SomazaS, ComeyC, LunsfordLD, ClaassenD, PandalaiS, MaitzA and FlickingerJC. (1996). Radiosurgery and fractionated radiation therapy: comparison of different techniques in an in vivo rat glioma model. J Neurosurg, 84:1033–1038.
39.
YangD, ZhangZJ, OldenburgM, AyalaM and ZhangSC. (2008). Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats. Stem Cells, 26:55–63.
40.
NakataniT, KumaiM, MizuharaE, MinakiY and OnoY. (2010). Lmx1a and Lmx1b cooperate with Foxa2 to coordinate the specification of dopaminergic neurons and control of floor plate cell differentiation in the developing mesencephalon. Dev Biol, 339:101–113.
41.
BarraudP, ThompsonL, KirikD, BjörklundA and ParmarM. (2005). Isolation and characterization of neural precursor cells from the Sox1-GFP reporter mouse. Eur J Neurosci, 22:1555–1569.
42.
AubertJ, StavridisMP, TweedieS, O'ReillyM, VierlingerK, LiM, GhazalP, PrattT, MasonJO, RoyD and SmithA. (2003). Screening for mammalian neural genes via fluorescence-activated cell sorter purification of neural precursors from Sox1-gfp knock-in mice. Proc Natl Acad Sci U S A, 100(Suppl 1):11836–11841.
43.
JonesL, López-BenditoG, GrussP, StoykovaA and MolnárZ. (2002). Pax6 is required for the normal development of the forebrain axonal connections. Development, 129:5041–5052.
44.
CalegariF, HaubensakW, HaffnerC and HuttnerWB. (2005). Selective lengthening of the cell cycle in the neurogenic subpopulation of neural progenitor cells during mouse brain development. J Neurosci, 25:6533–6538.
45.
OsumiN, ShinoharaH, Numayama-TsurutaK and MaekawaM. (2008). Concise review: Pax6 transcription factor contributes to both embryonic and adult neurogenesis as a multifunctional regulator. Stem Cells, 26:1663–1672.
46.
SerizawaT, IuchiT, OnoJ, SaekiN, OsatoK, OdakiM, UshikuboO, HiraiS, SatoM and MatsudaS. (2000). Gamma knife treatment for multiple metastatic brain tumors compared with whole-brain radiation therapy. J Neurosurg, 93(Suppl 3):32–36.
47.
LeeGS, ChoSJ, KimJH, ParkHK, ParkSQ, KimRS and JangJC. (2015). Comparative Analysis of Efficacy and Safety of Multisession Radiosurgery to Single Dose Radiosurgery for Metastatic Brain Tumors. Brain Tumor Res Treat, 3:95–102.
48.
GretoD, ScocciantiS, CompagnucciA, ArilliC, CasatiM, FrancoliniG, CecchiniS, LoiM, DesideriI, et al. (2016). Gamma Knife Radiosurgery in the management of single and multiple brain metastases. Clin Neurol Neurosurg, 141:43–47.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
